Completion date: 01 January 1996
Principal Investigator
Dr. Talaat bin Hamza Al-Waznah
Co-Investigators
None.
Research Outcome
Recommendations:
This drug was proved to reduce the myosclerosis and improve the functional performance of the patient. The drug has no side effects. It was shown that the patient’s response to the drug is directly proportional to his mental abilities and inversely proportional to the patient’s age and the number of the stiffened muscle groups.
Grantee Institution
N/A.
Partners
Disabled Children Association
Publication list
N/A.
Other Resources
N/A.
Links
N/A.